SPDR S&P Biotech shares owned by Princeton Global Asset Management
Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Princeton Global Asset Management
from 13F filings
Historical chart of Princeton Global Asset Management investment in SPDR S&P Biotech
Tip: Access up to 7 years of quarterly data
All positions including SPDR S&P Biotech held by Princeton Global Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in SPDR S&P Biotech by Princeton Global Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $208k | 1.6k | 127.73 |
| 2024-09-30 | $64k | 650 | 98.80 |
| 2024-06-30 | $60k | 650 | 92.71 |
| 2024-03-31 | $62k | 650 | 94.89 |
| 2023-12-31 | $58k | 650 | 89.29 |
| 2023-09-30 | $48k | 650 | 73.02 |
| 2023-06-30 | $96k | 1.2k | 83.20 |
| 2023-03-31 | $88k | 1.2k | 76.21 |
| 2022-12-31 | $95k | 1.2k | 82.61 |
| 2022-09-30 | $91k | 1.2k | 79.13 |
| 2022-06-30 | $85k | 1.2k | 73.91 |
| 2022-03-31 | $103k | 1.2k | 89.57 |
| 2021-12-31 | $129k | 1.2k | 112.17 |
More positions owned by Princeton Global Asset Management
View all positions for Princeton Global Asset Management